Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
BonnieMac, We already know this… eom
The shorts can’t afford to cover regardless of the price per share because they have sold Billions of shares more than the Outstanding, or even the Authorized, shares issued. They just have to keep selling “air shares” to kick their illegal selling down the road until AMC goes bankrupt. Well, AMC is not going bankrupt. The “RECKONING” is coming for the shorts and it will expose the SEC involvement as well. 🔥🩳🔥 Let’s GO!
I have a feeling the Kelli Austin involvement will be resolved rather quickly. Oh… and Happy Thanksgiving to all my fellow shareholders!
archilles, Could be, but usually those buys are typically 4,999 shares, in order to avoid the 5,000 trigger price.
Interesting… seeing dozens of small buys of 1500, 1600 and 1700 at the ASK throughout the day…
Confusion reigns… eom
Dusty18, I expect the dip to happen on Wednesday. GLTA!
The only disappointment here is Sagaliam. If anything, Enzolytics IP property has increased and management learned how to better handle the next SPAC or partnership. There will be another agreement, and probably a much more favorable one. GLTA!
P2D, I think the Custodian will leave that decision to the management of the incoming company.
mj1, So… is the Spanish company still in play, or was just a poor pump attempt?
BB, Many here did not think the Sagaliam agreement was equitable to the shareholders. Well, they may soon get their wish…. Here’s my opinion: The Sagaliam agreement may not have looked that great to some shareholders, but, imo, it was a way to get the word out about the most valuable medical paradigm in the history of medicine. The value of Enzolytics’ intellectual property will eventually be measured in the trillions, not by the billions that current treatments are measured, regardless of how it comes to market.
GG, Sorry, I am not well informed regarding Kelli Austin’s role in this Sagaliam agreement. Maybe someone else on this board can elaborate.
Quick question… Has the intellectual property increased or decreased during the Sagaliam agreement? Imo, it has increased, so if anything, Enzolytics is even more valuable to a potential partnership. Let’s go forward! GLTA!!
Big yawn… eom
BB, Those dumped shares will be bought up by those of us here for the patents and AI, but good luck!
We’re going to need a better rumor… eom
……………HODL……….. “I like this stock.”
varok, The custodian, Emergent, reduced the A/S from 7B to 6B about a year ago.
WINNEMUCCA, NV, November 16, 2023 – Hycroft Mining Holding Corporation (Nasdaq: HYMC) (“Hycroft” or “the Company”) is pleased to announce the latest drill results from its ongoing 2022-2023 exploration drill program (the “Drill Program”) at the Hycroft Mine, located in Nevada, a Tier-1 mining jurisdiction. Drilling focused on the existing Brimstone pit, which has long been known as only a disseminated gold deposit. The new drill results identified a new system of significant quartz veining containing very high-grade silver mineralization spanning 300 meters in strike length and remains open along strike. Additional assays are pending from follow-up core drilling in this area.
Results were received for three of the holes drilled comprising reverse circulation (“RC”) and core holes: H23R-5753, H23R-5760, and H23R-5771. Key highlights include:
Discovery of a new silver system at Brimstone as a result of applying a fresh perspective and following up on targets not previously tested.
H23R-5753 is Hycroft’s best hole ever drilled in its more than 30-year history and is confirmed with additional follow-up core drilling.
Results, when compiled with the rest of the Drill Program indicate the presence of more significant silver mineralization than previously understood at the Hycroft Mine.
MB, I wonder how fast the 5’s and 6’s will go tomorrow…
Ok… this volume is getting interesting… eom
BIO-key Showcasing Unique Identity, Authentication Innovations to Executives at Invite-Only Boston Cybersecurity Summit
Highlighting phoneless, tokenless, passwordless and lower cost phish resistant security options
BOSTON and HOLMDEL, N.J., Nov. 13, 2023 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) featuring phoneless, tokenless and passwordless Identity-Bound Biometric (IBB) multi-factor authentication (MFA) solutions, announced the company will sponsor the seventh annual Boston Cyber Security Summit. The one-day event will be held at the Westin Copley Place on November 14th.
The Boston Cyber Security Summit is an exclusive, invite-only event hosting approximately 300 C-Level & Senior Executives responsible for managing the information security frameworks within their organizations. BIO-key and other leading cybersecurity solution providers will present cutting-edge products and solutions to this all-executive audience in an intimate, non-trade show like setting.
BIO-key will showcase its differentiating capability on center stage to high-level decision makers, including: FIDO2-compliant passwordless authentication options that include phoneless and tokenless MFA, in addition to offering all of the traditional multi-factor authentication approaches commonly used in mainstream MFA solutions. Unlike any other product or solution in the authentication category, BIO-key’s IBB allows users to take advantage of a true biometric passwordless authentication solution that does not require the use of phones or tokens to assist in the authentication process. With phish-resistant MFA and passwordless authentication top of mind for organizations of all sizes and across all industries, conference attendees will learn how the company’s award-winning unified IAM platform, PortalGuard®, along with Identity-Bound Biometrics, helps fill a critical business use case that traditional MFA overlooks – users who cannot use a phone or token to authenticate.
“Multi-factor authentication is no longer just nice-to-have. For most organizations it’s becoming mandatory, whether due to tightening SEC, FTC or cyber insurer scrutiny. Adopting company-wide MFA is bringing new challenges to enterprises for whom phones or tokens are not a viable option for large subsets of their users. Traditional approaches to MFA can require painful and costly solutions and pose an unnecessary barrier to adoption for many companies,” said Mark Cochran, President of PortalGuard. “Cybersecurity solutions need to provide elite security, but they also need to offer the same level of flexibility and usability. That’s a big reason why we’re so excited about the unique capabilities of PortalGuard with the power of Identity-Bound Biometrics. This exclusive event will be a prime opportunity to differentiate our solutions and have meaningful discussions with key stakeholders.”
About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over thirty five million users. BIO-key allows customers to choose the right phish-resistant authentication factors for diverse use cases, including phoneless, tokenless and passwordless biometric options when users cannot use phones or tokens to sign in. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.
Engage with BIO-key
Facebook – Corporate: https://www.facebook.com/BIOkeyInternational/
LinkedIn – Corporate: https://www.linkedin.com/company/bio-key-international
Twitter – Corporate: @BIOkeyIntl
Twitter – Investors: @BIO_keyIR
StockTwits: BIO_keyIR
Investor Contacts
William Jones, David Collins
Catalyst IR
BKYI@catalyst-ir.com
212-924-9800
RV, We’re supposed to trust you when your alias was established yesterday?
“Alias Born 11/09/2023 10:28:35 PM”
Marvinj, Nope, nada, nothing…. Nothing on the SOS website has changed… zip, zero, … but welcome to the club!
That’s the volume I’ve been watching for. Let’s see what tomorrow brings. GLTA!
Laya, I bought a few on today’s dip. eom
BIO-key Awarded $800K Follow-On Order for Biometric User Authentication from Leading Government Defense Ministry
HOLMDEL, N.J., Nov. 06, 2023 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB) for phoneless, tokenless, passwordless and phish-resistant authentication experiences, announced that one of the world’s most respected government defense ministries has selected and awarded BIO-key a new $800k order, leveraging a previously announced three-year purchasing agreement. The defense ministry is accelerating its deployment of BIO-key biometric authentication to secure, yet simplify, access to its most critical information systems. This order, along with portions of earlier $340k and $150K orders received in Q3’23, is expected to be recognized during Q4’23.
The defense ministry continues to expand its BIO-key user authentication deployment into new programs and user scenarios, delivering convenient phoneless, tokenless, and passwordless authentication access to digital services for over 30,000 users. BIO-key expects that expansion of the programs using its solution to additional defense ministry personnel will result in other awards in future periods.
BIO-key’s secure biometric authentication platform has been integrated with the ministry’s virtual desktop infrastructure (VDI) capabilities to allow secure VDI-optimized biometric authentication without requiring phones or tokens. BIO-key has worked closely with the ministry’s cybersecurity team to integrate state-of-the-art, cloud-enabled biometric authentication with its authentication federation platform to deliver advanced and secure biometric access to systems and applications across organizational boundaries. Because BIO-key credentials are the individuals themselves, access cannot be shared, delegated, phished, or forgotten.
Jim Sullivan, BIO-key’s SVP Strategy and Chief Legal Officer, said, “When the stakes are at their highest, security must be uncompromising yet user-friendly. BIO-key’s relationship with this innovative customer continues to expand, as does interest from the defense vertical in general. Last week, we were pleased to announce the addition of another new government defense ministry customer. We are pleased to be trusted to provide the highest level of security possible by biometrically ensuring only the right user accesses the most sensitive information. BIO-key has a long history of providing very secure and robust solutions in government, defense, finance, retail, and other highly regulated industries, and we are finding that our superior user experience and cost-saving tokenless solution translates well to enterprise authentication."
About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over thirty-five million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.
BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; our ability to execute and deliver on contracts in Africa; our ability to expand into Asia, Africa and other foreign markets; our ability to integrate the operations and personnel of Swivel Secure into our business; fluctuations in foreign currency exchange rates; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2022 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise.
Engage with BIO-key:
Facebook – Corporate: https://www.facebook.com/BIOkeyInternational/
LinkedIn – Corporate: https://www.linkedin.com/company/bio-key-international
Twitter – Corporate: @BIOkeyIntl
Twitter – Investors: @BIO_keyIR
StockTwits: BIO_keyIR
Investor Contacts:
William Jones, David Collins
Catalyst IR
BKYI@catalyst-ir.com
212-924-9800
Bigblock, Thanks for the foresight. I’m new to gold mining, and only got here indirectly via AMC. Looking forward to learning more. Have a great week!
Saving Grace, According to the latest filing the company is currently not producing any gold or silver. They are in a strictly “Exploration and Development” phase at this time. This is all well and good as it seems the company has been preparing for production. So, all that concerns me now is the timeframe for production to begin. I anxiously await that announcement from Hycroft management that production “has begun”. That will be a special day for Hycroft and AMC investors. Good luck to all…
Bigblockwyz, Thanks for that info. I hope that Hycroft can actually produce some precious metals from their own mines at some point because I’m invested in AMC, which invested in Hycroft. I haven’t been able to determine a realistic timeframe for that happening. I’ll keep watching.
Saving Grace, I do not see anything in that communication that specifically says that the gold and silver used to forge the coins and bars come from ore mined in the Hycroft mines.
SG, Show me where the Gold and Silver for the coins and bars are being produced from ore mined from specifically Hycroft mines. Link please….
anavol, 300% dividend coming… ‘nuf said… eom
Dyno89, You do realize that Enzolytics, is producing “cure” rather than treatments. Which part of “cure” don’t you understand when trying to compare Enzolytics to other pharmaceuticals?
Mutat, Foolish… eom
29, I’ve never seen an MCAD indicator capable of incorporating an upcoming dividend into the charts.
SrApollo, I totally don’t agree with it when there is a 300% dividend on the table.
Fake screenshot. You just got ignored.
Fyi: “Your move from TD Ameritrade to Schwab is quickly approaching. That's why we want to make sure that thinkorswim users, like you, have the information needed to get up and running smoothly on the award-winning thinkorswim platform suite at Schwab.
After your account transitions, you'll have immediate access to thinkorswim desktop, web, and mobile. You'll be able to continue to use the same desktop and mobile downloads of thinkorswim that you use now—there's no need to download new software or apps.
When you log in to each thinkorswim platform for the first time after your move, your connection will need to be switched to Schwab—simply follow the prompts to do so.”